Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 14Breast 11Other 7Lymphoid 5Other hematologic neoplasm 4Gynecologic 4Genitourinary 4Endocrine 3Tumor-Agnostic 2Thoracic 2Myeloid 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Lung Neoplasms 1Fasting 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 1145Cisplatin 874Pemetrexed 832pembrolizumab 604Paclitaxel 597Docetaxel 535Gemcitabine 424Radiotherapy 374Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 294durvalumab 254Drug Therapy 233osimertinib 217atezolizumab 207Radiosurgery 188Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 123Magnetic Resonance Spectroscopy 120Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Diet × Thoracic × Clear all
NCT06671613 2025-11-10

Stage IV NSCLC

VA Office of Research and Development

Phase NA Recruiting
66 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Fasting

NCT03785808 2019-08-12

RIGHT

Fred Hutchinson Cancer Center

Phase NA Terminated
3 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡